Tracking Larry Robbins’ Glenview Capital Management Portfolio – Q4 2023 Update

• Glenview Capital Management’s 13F portfolio value increased from ~$4.4B to ~$4.7B this quarter. 
• They increased Cigna (CI), DXC Technology (DXC), Clarivate plc (CLVT) and Alight (ALIT) while reducing Fiserv (FISV) and Amazon.com (AMZN). 
• The top three individual stock stakes are Cigna (CI), Tenet Healthcare (THC), and DXC Technology (DXC). They add up to ~34% of the portfolio. 

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 2/14/2024. Please visit our Tracking Larry Robbins’ Glenview Capital Management Portfolio article for an idea on his investment philosophy and our previous update for the fund’s moves during Q3 2023.

 

This quarter, Robbins’ 13F portfolio value increased from ~$4.4B to ~$4.7B. There are 29 positions that are significantly large. The spreadsheet below lists those larger positions individually. The top five individual stock stakes are Cigna (CI), Tenet Healthcare (THC), DXC Technology (DXC), United Health Services (UHS), and Global Payments (GPN). Together they are at ~45% of the 13F assets.

 

 

The spreadsheet below highlights changes to Robbins’ 13F stock holdings in Q4 2023:

 

 

 

Source: John Vincent. Data constructed from Glenview Capital Management’s 13F filings for Q3 2023 and Q4 2023.